武田製藥 TAK 深滬

等待開盤 11-06 09:30:00 美东时间

13.605

+0.045

+0.33%

華盛通

立即下載

最高13.626
今開13.505
成交量 175.57万股
最低 13.495
昨收 13.56
總市值 429.65亿
52周最高 15.3686
市盈率 ^靜 61.70
換手率 0.06%
52周最低 12.2026
委比 11.00%
總股本 31.58亿
歷史最高 17.4247
量比 0.70
振幅 0.97%
歷史最低 8.7904
每手 1
風險率 0.82%

個股概要

財務分析

公司資料

分紅派息

分時圖
日k
周k
月k

相關新聞

医药巨头进博会“秀肌肉”：跨国药企在华建厂、扫货，中国创新药年内对外授权超1000亿美元

本文来源：时代财经作者：张羽岐 11月5日，以“开放共创新机遇，合作共享新未来”为主题的第八届中国国际进口博览会（下称“进博会”）在上海开幕。本届进博会吸引...

11-05 17:32
创新药行情震荡，调整已到位？港股通创新药ETF(159570)两连阳后首度调整近2%，昨日巨幅揽金超9.4亿元！机构：创新药行情有望重燃！

今日（11.4），创新药板块两连阳后首度调整，100%创新药含量的港股通创新药ETF（159570）回调1.73%，成交额已超15亿元！资金持续涌入，昨日巨幅揽...

11-04 11:26
强势上涨！重磅利好来了！

在重大会议和中美关税谈判鞋子落地后，国内股市重新进入分化状态，各赛道板块也回归自身的逻辑驱动。 11月3日，A港股大盘震荡收涨，上周重回上涨的创新药板块也继续表...

11-03 20:01
创新药迎“三箭齐发”！政策+研发+BD交易共振，港A概念股同步冲高

10月31日，受国家医保谈判首次引入“商保创新药目录”等多重利好推动，港A两市创新药概念股集体走强。 A股创新药板块表现活跃，截至收盘，三生国健、舒泰神20C...

10-31 15:08
【券商聚焦】国金证券维持信达生物(01801)“买入”评级指重磅产品顺利出海

金吾资讯

10-31 15:04
Takeda Lowers 2025 Outlook After Weak Q2 And Pipeline Impairment Charges

Takeda posts lower Q2 earnings and trims 2025 outlook as Vyvanse generics, FX headwinds, and impairment charges weigh on revenue and profit.

10-30 21:13
Earnings Scheduled For October 30, 2025

Companies Reporting Before The Bell • Altria Group (NYSE:MO) is projected to re...

10-30 19:12
European indexes mixed awaiting ECB interest rate decision

London (UKX) +0.61% to 9,756 Germany (DAX:IND) -0.64% to 24,124. France (CAC:IND) -0.19% to 8,201. France Q3 GDP expands more than estimates. Household consumption in France unexpectedly rose 0.3% ...

10-30 16:10
Takeda Pharmaceutical Q2 Adj. EPS $0.43 Misses $0.44 Estimate, Sales $7.520B Miss $8.080B Estimate

Takeda Pharmaceutical (NYSE:TAK) reported quarterly earnings of $0.43 per share which missed the analyst consensus estimate of $0.44 by 2.27 percent. This is a 4.44 percent decrease over earnings of $0.45 per share from

10-30 15:17
新晋女首富诞生，1400亿

乘上东风。

10-29 16:51

派息除權日	每股總股息	派息日期
2025-09-30	0.32
2025-03-31	0.32
2024-09-30	0.33	2024-09-30
2024-03-27	0.30	2024-03-27
2023-09-28	0.26	2023-12-11
2023-03-30	0.27	2023-07-10
2022-09-29	0.30	2022-09-29
2022-03-30	0.36	2022-03-30
2021-09-29	0.39	2021-09-29
2021-03-30	0.40	2021-03-30
2020-09-29	0.37	2020-09-29
2020-03-30	0.32	2020-07-06
2019-09-27	0.32	2019-12-12
2019-03-27	0.36	2019-06-28
2018-09-26	0.30	2018-12-01
2018-03-27	0.30	2018-07-09
2017-09-27	0.31	2017-12-01
2017-03-29	0.36	2017-07-10
2016-09-28	0.29	2016-12-12
2016-03-29	0.32	2016-07-11
2015-09-28	0.28	2015-12-11
2015-03-27	0.33	2015-06-01
2014-09-26	0.29	2014-12-11
2014-03-27	0.37	2014-06-30
2013-09-26	0.43	2013-12-01
2013-03-27	0.45	2013-06-01
2012-09-26	0.55	2012-09-26
2012-03-28	0.50	2012-07-09
2011-09-28	0.51	2011-12-12
2011-03-29	0.49	2011-07-07
2010-09-27	0.50	2010-12-13
2010-03-29	0.45	2010-07-14
2009-09-25	0.46	2009-12-15
2009-03-26	0.42	2009-07-14
2008-09-25	0.41	2008-12-16
2008-03-26	0.36	2008-03-26

公司名稱	Takeda Pharmaceutical Co., Ltd.
行業分類	Pharmaceuticals: Major
業務描述	Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

武田製藥 TAK 深 滬

13.605

個股概要

財務分析

公司資料

相關新聞

分紅派息

相關新聞

公司簡介

武田製藥 TAK 深滬